Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +12.50p +5.10% 257.50p 255.00p 260.00p 262.50p 245.00p 245.00p 111,903 14:23:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -21.0 -55.7 - 82.00

ReNeuron Group plc Exercise of options, PDMR dealing and TVR

09/05/2019 5:05pm

UK Regulatory (RNS & others)


Reneuron (LSE:RENE)
Historical Stock Chart

3 Months : From Apr 2019 to Jul 2019

Click Here for more Reneuron Charts.

TIDMRENE

RNS Number : 5752Y

ReNeuron Group plc

09 May 2019

 
 9 May 2019   AIM: RENE 
 

ReNeuron Group plc

Exercise of options, PDMR dealing and

total voting rights

ReNeuron Group plc (the "Company") (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces that it has received notices to exercise options from certain PDMRs of the Company to subscribe for a total of 65,792 new ordinary shares of 1 pence each in the Company ("Ordinary Shares").

On 9 May 2019, Sharon Grimster, VP Development and General Manager Wales, exercised options over 39,960 Ordinary Shares at an exercise price of 100 pence per share. Subsequently, on 9 May 2019, Mrs Grimster sold 39,960 Ordinary Shares at a share price of 267 pence.

On 9 May 2019, Dr Randolph Corteling, Head of Research, exercised options over 25,832 Ordinary Shares at an exercise price of 100 pence per share. Subsequently, on 9 May 2019, Dr Corteling sold 25,832 Ordinary Shares at a share price of 267 pence.

Total voting rights

Following the issue of 65,792 Ordinary Shares pursuant to the exercise of options described above, together with exercise of options by other staff under its existing blocklisting arrangements, the Company has 31,799,617 ordinary shares of 1 pence each in issue, all with voting rights. The Company holds no ordinary shares in treasury. The above figure of 31,799,617 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

S

ENQUIRIES:

 
ReNeuron                                         +44 (0)20 3819 8400 
Olav Hellebø, Chief Executive Officer 
Michael Hunt, Chief Financial Officer 
 
  Buchanan                                       +44 (0) 20 7466 5000 
Mark Court, Sophie Wills, Tilly Abraham 
 
 
Stifel Nicolaus Europe Limited                   +44 (0) 20 7710 7600 
Jonathan Senior, Stewart Wallace, Ben Maddison 
(NOMAD and Joint Broker) 
N+1 Singer                                       +44 (0) 20 7496 3000 
Aubrey Powell, Mark Taylor (Joint Broker) 
 

About ReNeuron

ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs. The Company's lead clinical-stage candidates are in development for disability as a result of stroke and for the blindness-causing disease, retinitis pigmentosa. ReNeuron is also advancing its proprietary exosome technology platform as a potential delivery system for drugs that would otherwise be unable to reach their site of action. ReNeuron's shares are traded on the London AIM market under the symbol RENE.L. For further information visit www.reneuron.com.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation and provide further detail.

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                         Sharon Grimster 
     ---------------------------  ----------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status              VP Development and General Manager 
                                    Wales 
     ---------------------------  ----------------------------------- 
 b)   Initial notification         Initial notification 
       /Amendment 
     ---------------------------  ----------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                         ReNeuron Group plc 
     ---------------------------  ----------------------------------- 
 b)   LEI                          2138003TU12CQ5TZO137 
     ---------------------------  ----------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of               Ordinary Shares of 1 pence each 
       the financial instrument, 
       type of instrument           RENE - GB00BF5G6K95 
       Identification 
       code 
     ---------------------------  ----------------------------------- 
 b)   Nature of the transaction    Exercise of options over ordinary 
                                    shares 
     ---------------------------  ----------------------------------- 
 c)   Price(s) and volume(s)         Price(s)     Volume(s) 
                                      100 pence    39,960 
                                                  ---------- 
     ---------------------------  ----------------------------------- 
 d)   Aggregated information       N/A 
     ---------------------------  ----------------------------------- 
 e)   Date of the transaction      09 May 2019 
     ---------------------------  ----------------------------------- 
 f)   Place of the transaction     London Stock Exchange, AIM Market 
     ---------------------------  ----------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                         Sharon Grimster 
     ---------------------------  ----------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status              VP Development and General Manager 
                                    Wales 
     ---------------------------  ----------------------------------- 
 b)   Initial notification         Initial notification 
       /Amendment 
     ---------------------------  ----------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                         ReNeuron Group plc 
     ---------------------------  ----------------------------------- 
 b)   LEI                          2138003TU12CQ5TZO137 
     ---------------------------  ----------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of               Ordinary Shares of 1 pence each 
       the financial instrument, 
       type of instrument           RENE - GB00BF5G6K95 
       Identification 
       code 
     ---------------------------  ----------------------------------- 
 b)   Nature of the transaction    Sale of ordinary shares 
     ---------------------------  ----------------------------------- 
 c)   Price(s) and volume(s)         Price(s)     Volume(s) 
                                      267 pence    39,960 
                                                  ---------- 
     ---------------------------  ----------------------------------- 
 d)   Aggregated information       N/A 
     ---------------------------  ----------------------------------- 
 e)   Date of the transaction      09 May 2019 
     ---------------------------  ----------------------------------- 
 f)   Place of the transaction     London Stock Exchange, AIM Market 
     ---------------------------  ----------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                          Randolph Corteling 
     ----------------------------  ---------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status               Head of Research 
     ----------------------------  ---------------------------------- 
 b)   Initial notification          Initial notification 
       /Amendment 
     ----------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                          ReNeuron Group plc 
     ----------------------------  ---------------------------------- 
 b)   LEI                           2138003TU12CQ5TZO137 
     ----------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of                Ordinary Shares of 1 pence each 
       the financial instrument, 
       type of instrument            RENE - GB00BF5G6K95 
       Identification 
       code 
     ----------------------------  ---------------------------------- 
 b)   Nature of the transaction     Exercise of options over ordinary 
                                     shares 
     ----------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)          Price(s)     Volume(s) 
                                       100 pence    25,832 
                                                   ---------- 
     ----------------------------  ---------------------------------- 
 d)   Aggregated information        N/A 
     ----------------------------  ---------------------------------- 
 e)   Date of the transaction       09 May 2019 
     ----------------------------  ---------------------------------- 
 f)   Place of the transaction      London Stock Exchange, AIM Market 
     ----------------------------  ---------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                          Randolph Corteling 
     ----------------------------  ---------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status               Head of Research 
     ----------------------------  ---------------------------------- 
 b)   Initial notification          Initial notification 
       /Amendment 
     ----------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                          ReNeuron Group plc 
     ----------------------------  ---------------------------------- 
 b)   LEI                           2138003TU12CQ5TZO137 
     ----------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of                Ordinary Shares of 1 pence each 
       the financial instrument, 
       type of instrument            RENE - GB00BF5G6K95 
       Identification 
       code 
     ----------------------------  ---------------------------------- 
 b)   Nature of the transaction     Sale of ordinary shares 
     ----------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)          Price(s)     Volume(s) 
                                       267 pence    25,832 
                                                   ---------- 
     ----------------------------  ---------------------------------- 
 d)   Aggregated information        N/A 
     ----------------------------  ---------------------------------- 
 e)   Date of the transaction       09 May 2019 
     ----------------------------  ---------------------------------- 
 f)   Place of the transaction      London Stock Exchange, AIM Market 
     ----------------------------  ---------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCEAKSNEEANEFF

(END) Dow Jones Newswires

May 09, 2019 12:05 ET (16:05 GMT)

1 Year Reneuron Chart

1 Year Reneuron Chart

1 Month Reneuron Chart

1 Month Reneuron Chart
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190717 15:34:09